AGP Picks
View all

Insurance Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Insurance Press Releases.

Press releases published on April 20, 2026

ALDX Investor Alert: Aldeyra Therapeutics Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Omitted Inconsistent Trial Data: Levi & Korsinsky
EOSE Investor Alert: EOS Energy Enterprises, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Misleading Institutional Shareholders: Levi & Korsinsky
CIGL Investor Alert: Concorde International Group Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Fabricated Growth Narrative: Levi & Korsinsky
GEMI Investor Alert: Gemini Space Station Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Misled on Strategic Direction: Levi & Korsinsky
Levi & Korsinsky, LLP: Navan Disclosure Timeline Reveals Pattern of Alleged Investor Harm
MNDY Investor Alert: monday.com Ltd. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Overstating Revenue Trajectory: Levi & Korsinsky
DRVN Investor Alert: Driven Brands Holdings Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Concealing Financial Reporting Failures: Levi & Korsinsky
GOSS Investor Alert: Gossamer Bio Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Concealing Clinical Execution Failures: Levi & Korsinsky
MEDP Investor Alert: Medpace Holdings Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After CEO Allegedly Certified Misleading Statements: Levi & Korsinsky
GO Investor Alert: Grocery Outlet Holding Corp. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After CEO Allegedly Certified Misleading Statements: Levi & Korsinsky
IBRX Investor Alert: ImmunityBio Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Chairman Allegedly Misled on Drug Efficacy: Levi & Korsinsky
Atara Biotherapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before May 22, 2026 to Discuss Your Rights – ATRA
UPST Investor Alert: Upstart Holdings Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Misled on AI Growth: Levi & Korsinsky
NKTR Investor Alert: Nektar Therapeutics Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Misleading Institutional Shareholders: Levi & Korsinsky
SMCI Investor Alert: Super Micro Computer Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Senior Executives Allegedly Enabled Illegal Exports: Levi & Korsinsky
Levi & Korsinsky Notifies Shareholders of Corcept Therapeutics Incorporated(CORT) of a Class Action Lawsuit and an Upcoming Deadline
SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Management Allegedly Concealed Drug Risks: Levi & Korsinsky
PSIX Investor Alert: Power Solutions International Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Concealed Margin Deterioration Timeline: Levi & Korsinsky
Levi & Korsinsky, LLP: PYPL Disclosure Timeline Reveals Pattern of Alleged Harm
TCOM Investor Alert: Trip.com Group Limited Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Understating Anti-Monopoly Regulatory Risk: Levi & Korsinsky

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Insurance Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.